Fabio Rosati, a director at Xometry Inc. (NASDAQ:XMTR), sold 1,800 shares of Class A common stock on November 9, 2026, for a total value of $216,938. The shares sold at prices between $119.334 and $122.3819, near the stock's 52-week high of $123.39.
The sales were executed under a Rule 10b5-1 trading plan that Rosati adopted at least 90 days prior to the transaction date. Following the sale, Rosati indirectly owns 89,867 shares through The Fabio Rosati 2022 Family Trust.
Xometry stock has gained over 100% year-to-date and 82% over the past year. According to InvestingPro analysis, the stock currently appears overvalued relative to its fair value.
In third-quarter results, Xometry reported adjusted earnings of $0.28 per share and revenue of $252.4 million, a 40% increase year-over-year. The quarter marked the company's first period of GAAP net income. Marketplace revenue grew 43% year-over-year to $238 million. Adjusted EBITDA reached $21.4 million, exceeding consensus estimates by approximately 28%.
Cantor Fitzgerald raised its price target to $114. Wedbush and Citizens raised theirs to $140 and $135, respectively. Xometry raised guidance for the fourth quarter of 2026 by approximately $7 million.
XOMETRY stock has delivered strong returns and now trades near 52-week highs. Investors should monitor XMTR price action and watch for any additional insider transactions or changes to analyst price targets.